Anastrozole provides alternative option for DCIS
June 2, 2015|ObGyn
Author and Disclosure Information
AT THE 2015 ASCO ANNUAL MEETING
Susan London/Frontline Medical News
ASCO expert Dr. Don Dizon agreed and said the results of B-35 answer a very important clinical question and will allow physicians who treat women with DCIS to counsel them on an individual level about their treatment options.
The study was funded by the National Institutes of Health. Dr. Margolese reported no relevant conflicts of interest. Dr. Dizon reported employment and a consultant or advisory board role with UpToDate and research funding to his institution from AstraZeneca and GlaxoSmithKline.
On Twitter @pwendl
